Condition: Stroke, Ischemic · Stroke Hemorrhagic · Sponsor: University of Pennsylvania
The investigators aim to examine whether amantadine can help patients recover from stroke. This will be a blinded randomized clinical trial (RCT). Patients will be randomized post-ischemic or hemorrhagic stroke either to the placebo arm or amantadine arm. Patients will be on study drug or placebo for 1 month but will be enrolled for 3 months total. At various time points patients will be examined and fill out questionnaires to determine level of stroke recovery.
This description comes directly from the study's public registry record.
Aaron Rothstein, M.D · 267-624-4442 · aaron.rothstein@pennmedicine.upenn.edu
Nichole Gallatti, M.S.Ed. · nichole.gallatti@pennmedicine.upenn.edu
Always discuss trial participation with your own doctor first.
| The Hospital of the University of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05140148